76.67 USD
↘ 3.02 (3.79%)AT CLOSE (11:59 AM EDT)
Arrowhead Research Corporation
ARWRNASDAQ • USD
76.56
↘ 0.11 (0.14%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
76.56
↘ 0.11 (0.14%)
Market: CLOSED
Open?$78.16
High?$79.00
Low?$76.26
Prev. Close?$79.69
Volume?1.7M
Avg. Volume?1.8M
VWAP?$77.27
Rel. Volume?0.96x
Bid / Ask
Bid?$65.61 × 100
Ask?$87.15 × 100
Spread?$21.54
Midpoint?$76.38
Valuation & Ratios
Market Cap?10.8B
Shares Out?140.9M
Float?134.8M
Float %?96.2%
P/E Ratio?N/A
P/B Ratio?17.59
EPS?-$2.14
Dividend?0.38%
Ex-Dividend?N/A
News
Profile
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
Themes
Employees
711
Market Cap
10.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1995-02-01
Address
177 E COLORADO BLVD
PASADENA, CA 91105
Phone: 626-696-4702
PASADENA, CA 91105
Phone: 626-696-4702
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.23Strong
Quick Ratio?6.23Strong
Cash Ratio?0.64Adequate
Debt/Equity?1.44Moderate
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?17.59HIGH▾
P/S?17.36HIGH▾
P/FCF?N/A▾
EV/EBITDA?-58.5CHEAP▾
EV/Sales?18.48HIGH▾
Returns & Efficiency
ROE?-49.0%WEAK▾
ROA?-13.3%WEAK▾
Cash Flow & Enterprise
FCF?$-50872000
Enterprise Value?$11.5B
Fundamentals ratios updated end of day